Share your ideas and thoughts., page-427

And let's remember that we will have NO COMPETITOR in this space - IHL has embarked on a strategy to come up with formulations to address markets for which there is no other treatment available.

The other important stat to bear in mind is that the CPAP has only captured 5% of the sleep apnea market (these are the words of Resmed chief executive Mick Farrell - https://www.copyright link/companies/healthcare-and-fitness/fitbits-smartwatches-to-help-boost-resmed-sales-20200130-p53wbf).

Does that mean that if we can then capture even just 20% of the addressable market (very conservative), we'll be worth 4x more than Resmed?? Simplistic way of looking at it but you get the idea